Home / Stocks / Gaudium Ivf N Women H L
GAUDIUMIVF

Gaudium Ivf N Women H L Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹99.44

Change

+2.04 (2.09%)

Open

₹97.01

Prev. Close

₹97.4

Day High

₹100.99

Day Low

₹96.42

Volume Analysis

Traded

222,929

Delivered

80,490

Delivery %

36.11%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (2)

  • •Strong return on equity (24.6%)
  • •Strong operating margin (31.0%)

Weaknesses (0)

No signal for this stock

Opportunities (2)

  • •Strong 3-year EPS growth (15.2%)
  • •Strong 3-year revenue growth (33.2%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹106.05 ₹103.52 ₹101.48 ₹98.95 ₹96.91 ₹94.38 ₹92.34
Fibonacci ₹103.52 ₹101.77 ₹100.7 ₹98.95 ₹97.2 ₹96.13 ₹94.38
Camarilla ₹100.7 ₹100.28 ₹99.86 ₹98.95 ₹99.02 ₹98.6 ₹98.18

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

-7.58%

1 Month

+4.73%

3 Months

-10.74%

6 Months

-13.58%

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹41.15

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

13.14%

Net margin 20.54% × asset turnover 0.52x × equity multiplier 1.23x

Company Overview

Sector

Healthcare

Market Cap

₹740 Cr

P/E (TTM)

32.0

ROE

24.6%

Book Value

₹22.4

Face Value

₹5.0

Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.

TopFund Analysis

Gaudium Ivf N Women H L lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 59/100. The strongest factor is Financial Strength (100/100), while Cash Flow (12/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (24.6%); strong operating margin (31.0%). FII holding has been falling.

TopFund Score — Fundamentals Quality

59/100 — Average

Data confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

88

Valuation

37

Cash Flow

12

Corporate Governance

56

Momentum

35

Institutional Ownership

22

Business Quality

99

Risk & Volatility

36

Liquidity

20

From Screener.in

  • +Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has high debtors of 187 days.
  • −Working capital days have increased from 39.9 days to 90.9 days

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Gaudium IVF and Women Health Limited has informed about Newspaper Publication for the Notice of Postal Ballot, remote e-voting information and form PAS-1 (Public Notice)

Audio recording of Q2 and H1 FY27 earnings call uploaded on November 16, 2026.

Investor Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 2026

Newspaper Publication of the unaudited and consolidated Financial Results for the quarter and half year ended September 30, 2026

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 14 27 18 32 25 30 19 37
Expenses + 9 18 13 18 18 18 17 24
Operating Profit 6 9 5 14 7 12 2 13
OPM % 39.25% 32.39% 29.0% 43.4% 26.76% 40.1% 12.54% 36.01%
Other Income + 0 0 0 0 0 0 1 1
Interest 0 0 1 1 1 1 0 1
Depreciation 1 0 1 1 0 1 1 1
Profit before tax 5 8 4 13 5 10 2 13
Tax % 27.72% 20.96% 24.01% 26.64% 26.96% 19.77% 27.76% 25.42%
Net Profit + 3 6 3 9 4 8 2 9
EPS in Rs 1 1 1 2 1 1 0 1
Raw PDF — — — — — — — —
YoY Sales growth — — — — 70 13 9 18

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 37 44 48 71 104 112
Expenses + 23 24 28 42 66 77
Operating Profit 14 20 19 29 38 35
OPM % 37.0% 46.0% 41.0% 41.0% 36.0% 31.0%
Other Income + 0 0 0 0 0 2
Interest 1 0 1 2 4 3
Depreciation 1 1 2 2 3 3
Profit before tax 12 18 17 25 32 30
Tax % 26.0% 26.0% 38.0% 25.0% 24.0% —
Net Profit + 9 14 10 19 24 23
EPS in Rs 1 2 2 3 3 3
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% —
Sales growth — 21 8 48 48 23

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 8 22 26 16 116 127
Borrowings + 6 12 17 21 25 23
Other Liabilities + 3 2 7 22 16 15
Total Liabilities 18 37 51 89 193 200
Fixed Assets + 4 18 19 18 18 52
CWIP 0 0 0 7 12 0
Investments 0 0 0 5 5 5
Other Assets + 14 18 32 58 158 143
Total Assets 18 37 51 89 193 200
Equity Capital 1 1 1 31 36 36

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + -1 24 3 9 7
Cash from Investing Activity + -1 -16 -5 -15 -88
Cash from Financing Activity + 3 5 -1 2 82
Net Cash Flow 0 13 -3 -5 2
Free Cash Flow -2 9 1 0 1
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 13 141 27 46 51

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 71.29% → 71.29%
  Mar 2026 Jun 2026 Sep 2026
Public 19.39% 23.47% 25.28%
Promoters 71.29% 71.29% 71.29%
FII 6.7% 3.01% 1.19%
DII 2.63% 2.22% 2.22%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Gaudium Ivf N Women H L (this stock) 740 32.0 4.55 24.6%
Zim Laboratories Limited 756 365.0 2.59 1.59%
Shree Ganesh Remedies Ltd 798 65.9 4.79 10.8%
Wanbury Limited 676 20.3 4.3 76.5%
Kilitch Drugs India Ltd 805 33.4 2.79 10.6%
Health X Platform Limited 862 510.0 1.36 0.44%
Rays Of Belief Limited 615 99.3 4.03 16.1%

Which Mutual Funds Hold Gaudium Ivf N Women H L?

Frequently Asked Questions about Gaudium Ivf N Women H L

Community Sentiment

What are other investors saying about Gaudium Ivf N Women H L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.